Recurrence of Wegener's granulomatosis after kidney transplantation. Successful re-induction of remission with cyclophosphamide

The American Journal of Medicine
T I SteinmanA S Fauci

Abstract

A patient with Wegener's granulomatosis underwent successful kidney transplantation. After four years he had a recurrence of his disease while being maintained on azathiorpine. Substitution of cyclophosphamide for azathioprine resulted in a rapid remission of the Wegener's granulomatosis. Renal function has remained stable, and the patient has done well. As previous reports have suggested, it appears that cyclophosphamide is the immunosuppressive drug of choice in the treatment of Wegener's granulomatosis and that azathioprine is not as effective as cyclophosphamide in the treatment of this form of systemic vasculitis.

Citations

Jun 1, 1994·Transplant Immunology·A R Morley
Feb 11, 1991·Mayo Clinic Proceedings·R W SchrinerJ V Donadio
Jun 1, 1991·The American Review of Respiratory Disease·N A Ettinger, E P Trulock
Apr 2, 1984·Klinische Wochenschrift·E P Leumann, J Briner
Oct 1, 2013·Clinical Kidney Journal·Venkatesh RajkumarRaja Ramachandran
Feb 14, 2018·Expert Review of Clinical Immunology·D Geetha, S Kant
Nov 22, 2013·Current Opinion in Rheumatology·Sarah Moran, Mark A Little
Jul 1, 1991·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·J S Cameron
Apr 1, 1985·Australian and New Zealand Journal of Medicine·G O LittlejohnS R Holdsworth
Oct 3, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D Geetha, P Seo
Mar 5, 2020·Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia·Cigdem MengusAhmet Ugur Yalcin
Oct 3, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·D GeethaF C Fervenza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.